MetriGenix Changes Name To Xceed Molecular, Focuses On Translating Novel Biomarker-Based Tests From Research Into Routine Clinical Use

TORONTO, Oct. 25 /PRNewswire/ -- MetriGenix Corp., a pioneer in the development of cost-effective, easy-to-use gene-expression analysis systems, announced today that it has changed its name to Xceed Molecular. The name change comes as the company transitions from development stage to a nimble, customer-focused business, with innovative products and services designed to translate biomarker-based tests from research into routine clinical use.